title: Persistent alopecia induced by vismodegib.
authors.affiliation: Department of Dermatology, CHU Lille, Lille, France.
authors.forename: S
authors.initials: S
authors.lastname: Alkeraye
authors.affiliation: Department of Dermatology, CHU Lille, Lille, France.
authors.forename: C
authors.initials: C
authors.lastname: Maire
authors.affiliation: Department of Dermatology, CHU Lille, Lille, France.
authors.forename: E
authors.initials: E
authors.lastname: Desmedt
authors.affiliation: Department of Dermatology, CHU Lille, Lille, France.
authors.forename: C
authors.initials: C
authors.lastname: Templier
authors.affiliation: Department of Dermatology, CHU Lille, Lille, France.
authors.forename: L
authors.initials: L
authors.lastname: Mortier
mesh_terms: D000328:Adult; D000369:Aged, 80 and over; D000505:Alopecia / Q000139:chemically induced*; D000813:Anilides / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; C538724:HhAntag691; D011725:Pyridines